Product Image

Double Strength Ginkgo Biloba 120 mg

NOW
4.8
★ ★ ★ ★ ★
(38566 ratings)
Ginkgo
Eleuthero 250 mg
Product Image
Score80
A well-sized ginkgo serving in a practical package, with incomplete marker and purity disclosure as the main quality gap.
How scoring works
Quantity:100 Capsule(s) • (100 servings)
Goals:
Brain Health
Cognitive Support
Productivity Boost
Mental Focus

Score 80

A well-sized ginkgo serving in a practical package, with incomplete marker and purity disclosure as the main quality gap.
How scoring works

Also available as

2 options
200 servings Eleuthero 250 mg, Ginkgo 120 mg • 200 Capsule(s) • 200 servings $21.84 ($0.10 per serving) 50 servings Eleuthero 250 mg, Ginkgo 120 mg • 50 Capsule(s) • 50 servings $6.97 ($0.13 per serving)
$10.76($0.10 per serving)
iHerb
$ 13.46
Vitacost
$ 14.67
iHerb
$ 13.46
Daily Vita
$ 12.70
Amazon
$ 10.76
Report prices

Analysis

The ginkgo amount is aligned with common daily extract use and directly supports a cerebral-circulation approach to cognition. Eleuthero adds a possible stress-fatigue angle, though its contribution is secondary.

The label names flavonglycosides and terpene lactones without giving their percentages. It also omits a ginkgolic-acid limit, while the eleuthero entry lacks plant-part and standardization details.

The hundred-serving package is practical for adults who want a simple, non-caffeine botanical routine. Cognitive and focus use is more plausible than broad vision support, and bleeding-risk interactions remain an important purchasing consideration.

Who is it for
  • Adults seeking daily ginkgo-based cognitive support
  • People who prefer a non-stimulant capsule
Best for
  • Regular cognitive-support use
  • Cerebral-circulation and stress-stamina support

Pros

  • Provides 120 mg of ginkgo extract
  • Names both major ginkgo marker groups
  • Includes 250 mg of organic eleuthero
  • Offers 100 servings

Cons

  • Marker percentages are not stated
  • No ginkgolic-acid limit is supplied
  • Eleuthero is low and unstandardized
  • Vision coverage is narrow

Warnings

  • Ginkgo may increase bleeding risk with anticoagulant or antiplatelet medicines and before surgery.
  • Eleuthero may affect blood pressure or stimulant sensitivity in some users.

Nutrient quality

78 High impact

The ginkgo amount is practical and the marker groups are identified. Missing marker percentages, purity limits, and eleuthero standardization reduce confidence in quality.

.

Ingredient transparency

76 High impact

Both botanical amounts are disclosed without a hidden blend. Intake directions, inactive ingredients, and important extract details are not supplied.

.

Customer satisfaction

73 High impact

The supplied average rating is strong and comes from a very large rating pool. No firsthand experiences or recurring complaint details were provided, so consistency remains uncertain.

.

Value for money

93 Highest impact

A practical ginkgo amount and very low serving cost create strong value. Missing marker percentages are the main quality limitation.

.
Report analysis

Goals

Brain Health
Brain Health
Impact
Highest effect
A- Goal FitA- Strength of SupportB CoverageA- Formula Quality

Ginkgo directly targets cerebral circulation and has relevant human evidence for cognitive support. The disclosed extract amount is well aligned with common clinical use.

Both major ginkgo marker groups are named, but their percentages and a ginkgolic-acid limit are missing. Ginkgo may raise bleeding risk with anticoagulant or antiplatelet drugs, so concurrent use needs specific medical review.

Study evidence
Ginkgo Supportive 90 studies
Cognitive Support
Cognitive Support
Impact
Highest effect
B Goal FitA Strength of SupportC+ CoverageB+ Formula Quality

Ginkgo may support cerebral blood flow and selected aspects of memory, giving it a direct cognitive mechanism. The 120 mg extract amount is disclosed with flavonglycoside and terpene-lactone markers, while eleuthero adds stress-fatigue support.

Evidence is mixed for cognitive enhancement in healthy adults and is more relevant to age-related decline or circulation-related needs. Ginkgo can increase bleeding risk with anticoagulant or antiplatelet medicines and around surgery.

Study evidence
Eleuthero No effect 1 study
Ginkgo Supportive 87 studies
Productivity Boost
Productivity Boost
Impact
High effect
B- Goal FitB- Strength of SupportC- CoverageB+ Formula Quality
Eleuthero · 250 mgEleuthero · 250 mg

Ginkgo extract may support memory and cerebral circulation, while eleuthero may help with stress-related fatigue. The ginkgo amount is clinically plausible, but the eleuthero powder is below a meaningful range.

Both ginkgo marker groups are named without percentages, and eleuthero lacks plant-part and standardization details. Ginkgo may increase bleeding risk with anticoagulants or antiplatelet medicines, while eleuthero may aggravate stimulant sensitivity or blood-pressure concerns.

Study evidence
Eleuthero No effect 1 study
Eleuthero Not classified

No linked studies yet.

Ginkgo Supportive 20 studies
Ginkgo Supportive 12 studies
Mental Focus
Mental Focus
Impact
High effect
B Goal FitC+ Strength of SupportC CoverageB Formula Quality

Ginkgo may support focus through cerebral circulation and related cognitive mechanisms. Human evidence is mixed and depends heavily on using a well-standardized extract.

The 120 mg ginkgo amount is useful, but marker percentages and a ginkgolic acid limit are missing. Ginkgo may increase bleeding risk with anticoagulant or antiplatelet medicines, while eleuthero may affect stimulant sensitivity.

Study evidence
Eleuthero Disputed 3 studies
Ginkgo Supportive 28 studies
Vision Support
Vision Support
Impact
Moderate effect
D- Goal FitC Strength of SupportF CoverageC Formula Quality

Ginkgo supplies a possible ocular-circulation pathway at a clinically used extract amount. The label names both major marker groups but omits their standardization percentages and purity limits.

Eleuthero adds stress and energy support rather than direct macular or retinal protection. Ginkgo may increase bleeding risk with anticoagulants or antiplatelet medicines, while eleuthero may affect blood pressure or stimulant sensitivity.

Study evidence
Ginkgo Supportive 11 studies

Ingredients

IngredientAmount per serving
Ginkgo extract (Ginkgoflavonglycosides, Terpene Lactones)
 120 mg
organic Eleuthero
250 mg
Gluten Free Men 18–50 Vegan Kosher Women Vegetarian
Report overview
Ginkgo (Ginkgoflavonglycosides, Terpene Lactones) · 120 mg OverallScore66
F Active Ingredient Quality & BioavailabilityA+ Dose, Safety & Label TransparencyA+ Value

The full clinical extract amount is clearly disclosed at a very low serving cost. Both major marker groups are named, but their percentages and a ginkgolic-acid purity standard are missing. Ginkgo may raise bleeding risk with anticoagulants or antiplatelet drugs, while added eleuthero may also affect blood pressure or stimulant sensitivity.

View ingredientView products
Eleuthero · 250 mg OverallScore29
F Active Ingredient Quality & BioavailabilityD+ Dose, Safety & Label TransparencyF Value

The formula includes a modest amount of organic eleuthero alongside its primary ginkgo extract. Neither the plant part nor standardization is disclosed, so eleuthero quality and potency are uncertain. The amount is below the effective threshold for raw powder and does not earn meaningful eleuthero value.

View ingredientView products
Loading alternative details
83 Performance

Ginkgold 120 mg

Nature's Way
<p>It offers a stronger ingredient-quality case because 120 mg of branded Ginkgold provides a well-standardized ginkgo extract with strong purity disclosure. Compared with Double Strength Ginkgo Biloba 120 mg, it omits eleuthero, and ginkgo may add to bleeding risk with anticoagulant or antiplatelet medicines.</p>
84 Performance

Ginkgo Biloba Phytosome 60 mg

Natural Factors HerbalFactors
<p>It offers a stronger ingredient-quality case because 60 mg of recognized GinkgoSelect phytosome provides enhanced-delivery ginkgo in a focused formula. Compared with Double Strength Ginkgo Biloba 120 mg, the smaller amount is designed around phytosome delivery, although the supplied facts do not state every active-marker percentage.</p>
79 Performance

Dual Ginseng Plus

Swanson Superior Herbs
<p>It offers a stronger ingredient-quality case because 200 mg of eleuthero extract is paired with standardized American and Korean ginseng plus ashwagandha. Compared with Double Strength Ginkgo Biloba 120 mg, it omits ginkgo, so it better matches the adaptogen side of the original than its direct ginkgo component.</p>
84 Budget

Ginkgo Biloba Certified Extract 120 mg

Life Extension
<p>It lowers the recurring cost while 120 mg of ginkgo names both key marker groups and states a very low ginkgolic-acid limit. Compared with Double Strength Ginkgo Biloba 120 mg, it omits eleuthero, and ginkgo may add to bleeding risk with anticoagulant or antiplatelet medicines.</p>
83 Budget

Ginkgo Biloba 60 mg

Swanson Superior Herbs
<p>It lowers the recurring cost while 60 mg of GinkgoSelect supplies a standardized maintenance-level ginkgo extract. Compared with Double Strength Ginkgo Biloba 120 mg, the amount is lower than the original’s 120 mg or larger ginkgo serving, and ginkgo may add to bleeding risk with anticoagulant or antiplatelet medicines.</p>
84 Budget

Ginkgo Biloba 120 mg

Nature's Bounty
<p>It lowers the recurring cost while 120 mg of ginkgo names both flavone glycosides and terpene lactones in a simple formula. Compared with Double Strength Ginkgo Biloba 120 mg, marker percentages and a purity limit are missing, and the formula omits eleuthero.</p>
81 Value

Extra Strength Ginkgo 120 mg

Doctor's Best
<p>It balances formulation quality and cost because 120 mg of ginkgo extract names both flavonol glycosides and terpene lactones. Compared with Double Strength Ginkgo Biloba 120 mg, marker percentages and a purity limit are incomplete, and ginkgo may add to bleeding risk with relevant medicines.</p>
81 Value

Eleuthero Glycerite

Herb Pharm
<p>It balances formulation quality and cost because 817 mg of clearly identified eleuthero root extract provides a focused alcohol-free adaptogen option. Compared with Double Strength Ginkgo Biloba 120 mg, it omits ginkgo and does not state an extract ratio or eleutheroside percentage.</p>
84 Value

Ginkgo Biloba 120 mg

California Gold Nutrition EuroHerbs
<p>It balances formulation quality and cost because 120 mg of ginkgo names both flavone glycosides and terpene lactones at a practical recurring cost. Compared with Double Strength Ginkgo Biloba 120 mg, marker percentages and a purity guarantee are absent, and the formula does not include eleuthero.</p>
Report alternatives

Sources

Published studies used for the product analysis and the top-ranked studies for each ingredient and goal.

  1. Efficacy of Ginkgo biloba extract EGb 761® in dementia with behavioural and psychological symptoms: A systematic review.
    von Gunten A; Schlaefke S; Überla K · The world journal of biological psychiatry : the official journal of the World Federation of Societies of Biological Psychiatry · 2017
    Meta-analysis1,628 participants4 studies pooledCognitive Support Brain Health forGinkgo
  2. Ginkgo biloba Extract (EGb761), Cholinesterase Inhibitors, and Memantine for the Treatment of Mild-to-Moderate Alzheimer's Disease: A Network Meta-Analysis.
    Thancharoen O; Limwattananon C; Waleekhachonloet O; Rattanachotphanit T; Limwattananon P; Limpawattana P · Drugs & aging · 2019
    Meta-analysisCognitive Support forGinkgo
  3. Alleviating neuropsychiatric symptoms in dementia: the effects of Ginkgo biloba extract EGb 761. Findings from a randomized controlled trial.
    Bachinskaya N; Hoerr R; Ihl R · Neuropsychiatric disease and treatment · 2011
    Randomized trial410 participantsCognitive Support forGinkgo
  4. Efficacy and adverse effects of ginkgo biloba for cognitive impairment and dementia: a systematic review and meta-analysis.
    Tan MS; Yu JT; Tan CC; Wang HF; Meng XF; Wang C; Jiang T; Zhu XC; Tan L · Journal of Alzheimer's disease : JAD · 2015
    Meta-analysis2,561 participants9 studies pooledBrain Health forGinkgo
  5. Ginkgo biloba extract EGb 761 is safe and effective in the treatment of mild dementia - a meta-analysis of patient subgroups in randomised controlled trials.
    Riepe M; Hoerr R; Schlaefke S · The world journal of biological psychiatry : the official journal of the World Federation of Societies of Biological Psychiatry · 2025
    Meta-analysis782 participants4 studies pooledBrain Health Productivity Boost forGinkgo
  6. Ginkgo biloba extract EGb 761® improves cognition and overall condition after ischemic stroke: Results from a pilot randomized trial.
    Cui M; You T; Zhao Y; Liu R; Guan Y; Liu J; Liu X; Wang X; Dong Q · Frontiers in pharmacology · 2023
    Randomized trial201 participantsBrain Health Productivity Boost forGinkgo
  7. Ginkgo biloba extract EGb 761® in dementia with neuropsychiatric features: a randomised, placebo-controlled trial to confirm the efficacy and safety of a daily dose of 240 mg.
    Herrschaft H; Nacu A; Likhachev S; Sholomov I; Hoerr R; Schlaefke S · Journal of psychiatric research · 2012
    Randomized trial410 participantsBrain Health forGinkgo
  8. No benefit adding eleutherococcus senticosus to stress management training in stress-related fatigue/weakness, impaired work or concentration, a randomized controlled study.
    Schaffler K; Wolf OT; Burkart M · Pharmacopsychiatry · 2014
    Randomized trial144 participantsCognitive Support Mental Focus Productivity Boost forEleuthero
  9. Efficacy of ginkgo diterpene lactone meglumine on cognitive function in patients with acute ischemic stroke: a predefined exploratory analysis of a multicenter, double-blind, randomized controlled trial.
    Tian X; Xu Q; Xia X; Zhang Y; Meng X; Wang A · Journal of neurology · 2024
    Randomized trial3,163 participantsCognitive Support forGinkgo
  10. A placebo-controlled, double-blind, randomized trial of an extract of Ginkgo biloba for dementia. North American EGb Study Group.
    Le Bars PL; Katz MM; Berman N; Itil TM; Freedman AM; Schatzberg AF · JAMA · 1997
    Randomized trial309 participantsCognitive Support Productivity Boost forGinkgo
  11. Efficacy and safety of a once-daily formulation of Ginkgo biloba extract EGb 761 in dementia with neuropsychiatric features: a randomized controlled trial.
    Ihl R; Bachinskaya N; Korczyn AD; Vakhapova V; Tribanek M; Hoerr R; Napryeyenko O; GOTADAY Study Group · International journal of geriatric psychiatry · 2013
    Randomized trial410 participantsCognitive Support forGinkgo
  12. Evidence-based efficacy of adaptogens in fatigue, and molecular mechanisms related to their stress-protective activity.
    Panossian A; Wikman G · Current clinical pharmacology · 2009
    Narrative reviewMental Focus forEleuthero
  13. Stimulating effect of adaptogens: an overview with particular reference to their efficacy following single dose administration.
    Panossian A; Wagner H · Phytotherapy research : PTR · 2005
    Narrative reviewMental Focus forEleuthero
  14. Ginkgo biloba Extract EGb 761 in the Treatment of Patients with Mild Neurocognitive Impairment: A Systematic Review.
    Hort J; Duning T; Hoerr R · Neuropsychiatric disease and treatment · 2023
    Systematic review946 participants9 studies pooledMental Focus forGinkgo
  15. Proof of efficacy of the Ginkgo biloba special extract EGb 761 in outpatients suffering from mild to moderate primary degenerative dementia of the Alzheimer type or multi-infarct dementia.
    Kanowski S; Herrmann WM; Stephan K; Wierich W; Hörr R · Phytomedicine : international journal of phytotherapy and phytopharmacology · 2012
    Randomized trial216 participantsMental Focus forGinkgo
  16. Proof of efficacy of the ginkgo biloba special extract EGb 761 in outpatients suffering from mild to moderate primary degenerative dementia of the Alzheimer type or multi-infarct dementia.
    Kanowski S; Herrmann WM; Stephan K; Wierich W; Hörr R · Pharmacopsychiatry · 1996
    Randomized trial216 participantsMental Focus forGinkgo
  17. Ginkgo biloba extract improved cognitive and neurological functions of acute ischaemic stroke: a randomised controlled trial.
    Li S; Zhang X; Fang Q; Zhou J; Zhang M; Wang H; Chen Y; Xu B; Wu Y; Qian L; Xu Y · Stroke and vascular neurology · 2021
    Randomized trial348 participantsMental Focus forGinkgo
  18. Ginkgo biloba in the Aging Process: A Narrative Review.
    Barbalho SM; Direito R; Laurindo LF; Marton LT; Guiguer EL; Goulart RA; Tofano RJ; Carvalho ACA; Flato UAP; Capelluppi Tofano VA; Detregiachi CRP; Bueno PCS; Girio RSJ; Araújo AC · Antioxidants (Basel, Switzerland) · 2024
    Narrative review14 studies pooledMental Focus forGinkgo
  19. [Ginkgo biloba extract EGb 761 in the treatment of dementia: evidence of efficacy and tolerability].
    Kasper S; Schubert H · Fortschritte der Neurologie-Psychiatrie · 2009
    Meta-analysis10 studies pooledProductivity Boost forGinkgo
  20. Dietary Flavonoids and Human Cognition: A Meta-Analysis.
    Cheng N; Bell L; Lamport DJ; Williams CM · Molecular nutrition & food research · 2022
    Meta-analysis5,519 participants80 studies pooledProductivity Boost forGinkgo
  21. Limited cognitive benefits in Stage +2 postmenopausal women after 6 weeks of treatment with Ginkgo biloba.
    Elsabagh S; Hartley DE; File SE · Journal of psychopharmacology (Oxford, England) · 2005
    Randomized trial87 participantsProductivity Boost forGinkgo
  22. Efficacy and safety of Ginkgo biloba extract EGb 761 in mild cognitive impairment with neuropsychiatric symptoms: a randomized, placebo-controlled, double-blind, multi-center trial.
    Gavrilova SI; Preuss UW; Wong JW; Hoerr R; Kaschel R; Bachinskaya N; GIMCIPlus Study Group · International journal of geriatric psychiatry · 2015
    Randomized trial160 participantsProductivity Boost forGinkgo
  23. Modulation of cognitive performance following single doses of 120 mg Ginkgo biloba extract administered to healthy young volunteers.
    Kennedy DO; Jackson PA; Haskell CF; Scholey AB · Human psychopharmacology · 2008
    Randomized trial78 participantsProductivity Boost forGinkgo
  24. Effect of Ginkgo biloba extracts in the prevention of posterior capsule opacification after cataract surgery: A randomized clinical trial.
    Amiri AA; Jafari R; Amiri AA; Rad HA; Daneshvar F; Charati JY; Amiri AA · Oman journal of ophthalmology · 2025
    Randomized trial144 participantsVision Support forGinkgo
  25. Effect of Ginkgo biloba extract on preexisting visual field damage in normal tension glaucoma.
    Quaranta L; Bettelli S; Uva MG; Semeraro F; Turano R; Gandolfo E · Ophthalmology · 2003
    Randomized trial27 participantsVision Support forGinkgo
  26. [Ginkgo extract in impaired vision--treatment with special extract EGb 761 of impaired vision due to dry senile macular degeneration].
    Fies P; Dienel A · Wiener medizinische Wochenschrift (1946) · 2002
    Randomized trial99 participantsVision Support forGinkgo
  27. Short-term effects of Ginkgo biloba extract on peripapillary retinal blood flow in normal tension glaucoma.
    Park JW; Kwon HJ; Chung WS; Kim CY; Seong GJ · Korean journal of ophthalmology : KJO · 2012
    Randomized trial30 participantsVision Support forGinkgo
  28. [The course of color vision in early diabetic retinopathy treated with Ginkgo biloba extract. A preliminary double-blind versus placebo study].
    Lanthony P; Cosson JP · Journal francais d'ophtalmologie · 1989
    Randomized trial29 participantsVision Support forGinkgo